Therapy Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

Therapy Name 177Lu-rhPSMA-10.1
Synonyms
Therapy Description

177Lu-rhPSMA-10.1 is a radioconjugate comprising the radionuclide lutetium-177 linked to a PSMA-targeted ligand, PSMA-10.1, which delivers radiation to PSMA-expressing tumor cells, potentially resulting in increased tumor cell death and antitumor activity (PMID: 36692961, NCI Drug Dictionary).

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Drug Name Trade Name Synonyms Drug Classes Drug Description
177Lu-rhPSMA-10.1 177Lu rhPSMA-10.1|(177Lu) rhPSMA-10.1|Lutetium Lu 177 PSMA-10.1 177Lu-rhPSMA-10.1 is a radioconjugate comprising the radionuclide lutetium-177 linked to a PSMA-targeted ligand, PSMA-10.1, which delivers radiation to PSMA-expressing tumor cells, potentially resulting in increased tumor cell death and antitumor activity (PMID: 36692961, NCI Drug Dictionary).

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Molecular Profile Indication/Tumor Type Response Type Therapy Name Approval Status Evidence Type Efficacy Evidence References

Filtering

  • Case insensitive filtering will display rows if any text in any cell matches the filter term
  • Use simple literal full or partial string matches
  • Separate multiple filter terms with a space. Any order may be used (i. e. a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page. Filtering has no impact on query parameters.
  • Use quotes to match on a longer phrase with spaces (i.e. "mtor c1483f")

Sorting

  • Generally, the default sort order for tables is set to be first column ascending; however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column. Be sure to set ascending or descending order for a given column before moving on to the next column.

Clinical Trial Phase Therapies Title Recruitment Status Covered Countries Other Countries
NCT06059014 Phase Ib/II 177Lu-rhPSMA-10.1 Phase I/II Study Evaluating PSMA Targeted Radionuclide Therapy in Adult Patients With Metastatic Clear Cell Renal Cancer (PRadR) Recruiting FRA 0
NCT05413850 Phase Ib/II 177Lu-rhPSMA-10.1 Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection Recruiting USA | NLD 0
NCT06401980 Phase II Docetaxel Radium Ra 223 dichloride 177Lu-rhPSMA-10.1 Darolutamide Olaparib Cabazitaxel Darolutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Recruiting CHE 0
NCT06105918 Phase I 177Lu-rhPSMA-10.1 Radioligand Therapy After PSMA PET Guided External Beam Radiotherapy for Treating Post-Prostatectomy Patients With Biochemically Recurrent Prostate Cancer Recruiting USA 0


Additional content available in CKB BOOST